These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39074551)

  • 1. Early Outcomes of Prostatic Artery Embolization using n-Butyl Cyanoacrylate Liquid Embolic Agent: A Safety and Feasibility Study.
    Bamshad D; Sanghvi J; Galla N; Geffner A; Menon K; Bishay V; Shilo D; Garcia-Reyes K; Lookstein R; Rastinehad A; Fischman A
    J Vasc Interv Radiol; 2024 Jul; ():. PubMed ID: 39074551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients.
    Loffroy R; Quirantes A; Guillen K; Mazit A; Comby PO; Aho-Glélé LS; Chevallier O
    Diagn Interv Imaging; 2024 Apr; 105(4):129-136. PubMed ID: 38161141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Artery Embolization Using N-Butyl Cyanoacrylate Glue for Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Valid Alternative to Microparticles?
    Loffroy R; Guillen K; Salet E; Marcelin C; Comby PO; Midulla M; Grenier N; Chevallier O; Petitpierre F
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Butyl Cyanoacrylate Glue Versus Nonspherical Polyvinyl Alcohol Particles For Prostatic Arterial Embolization To Treat Benign Prostatic Hyperplasia: Safety and Efficacy.
    Hijazi BA; Shi HB; Liu S; Alqurashi TA; Sabri ZJ
    Urol J; 2023 Jul; 20(4):261-268. PubMed ID: 37330691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic Artery Embolization for Benign Prostatic Obstruction: Single-Centre Retrospective Study Comparing Microspheres Versus n-Butyl Cyanoacrylate.
    Salet E; Crombé A; Grenier N; Marcelin C; Lebras Y; Jambon E; Coussy A; Cornelis FH; Petitpierre F
    Cardiovasc Intervent Radiol; 2022 Jun; 45(6):814-823. PubMed ID: 35266024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia.
    Brown N; Walker D; McBean R; Pokorny M; Kua B; Gianduzzo T; Dunglison N; Esler R; Yaxley J
    BJU Int; 2018 Nov; 122 Suppl 5():27-34. PubMed ID: 30076682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The First 48 Consecutive Patients with 3-Year Symptom Score Follow-Up Post-Prostate Artery Embolization (PAE) at a Single-Centre University Hospital.
    Maclean D; Harris M; Long J; Modi S; Bryant TJ; Hacking N
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):459-465. PubMed ID: 31797101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic Artery Embolization for Lower Urinary Tract Symptoms via Transradial Versus Transfemoral Artery Access: Single-Center Technical Outcomes.
    Gil R; Shim DJ; Kim D; Lee DH; Kim JJ; Lee JW
    Korean J Radiol; 2022 May; 23(5):548-554. PubMed ID: 35506528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year experience with arterial embolization for peptic ulcer bleeding: N-butyl cyanoacrylate glue versus other embolic agents.
    Loffroy R; Desmyttere AS; Mouillot T; Pellegrinelli J; Facy O; Drouilllard A; Falvo N; Charles PE; Bardou M; Midulla M; Aho-Gléglé S; Chevallier O
    Eur Radiol; 2021 May; 31(5):3015-3026. PubMed ID: 33128601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat Prostatic Artery Embolization with the Addition of a Liquid Embolic Agent: Short-term Results.
    Guerra X; Sapoval M; Querub C; Al Ahmar M; Di Gaeta A; Dean C; Pellerin O; Boeken T
    Acad Radiol; 2024 May; 31(5):1959-1967. PubMed ID: 37996363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic artery occlusion versus prostatic artery embolisation for the management of benign prostatic hyperplasia: early results in a canine model.
    Lucas-Cava V; Sánchez-Margallo FM; Dávila-Gómez L; Lima-Rodríguez JR; Sun F
    Br J Radiol; 2022 Aug; 95(1136):20220243. PubMed ID: 35762334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Prostate Artery Embolization on Erectile Function - A Single Center Experience of 167 Patients.
    Bhatia S; Acharya V; Jalaeian H; Kumar J; Bryant E; Richardson A; Malkova K; Harward S; Sinha V; Kably I; Kava BR
    J Sex Med; 2022 Apr; 19(4):594-602. PubMed ID: 35184995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical and Imaging Outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on Predictors of Clinical Success.
    Hacking N; Vigneswaran G; Maclean D; Modi S; Dyer J; Harris M; Bryant T
    Cardiovasc Intervent Radiol; 2019 May; 42(5):666-676. PubMed ID: 30603967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year outcomes after prostate artery embolization versus laser enucleation: A network meta-analysis.
    Bhatia A; Porto JG; Maini A; Langade D; Herrmann TRW; Shah HN; Bhatia S
    BJUI Compass; 2024 Mar; 5(2):189-206. PubMed ID: 38371212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.